Advantages of Helicos BioSciences' single molecule sequencing technology presented

Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that, as previously disclosed, it has posted a presentation on its website regarding the advantages of Helicos’ single molecule sequencing technology in clinical diagnostics. The presentation, made by Stanley N. Lapidus, Chairman of the Company, can be accessed through the investor relations section of the Company’s website at The presentation will be available on the website until January 4, 2010.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
U of A researcher one step closer to demonstrating the potential of brain molecule to halt MS